Gold Coast Hospital & Health Service to trial HeraCARE for high-risk pregnancies
The Gold Coast Hospital and Health Service (GCHHS) is currently undertaking an ambitious digital transformation program for the health...
top of page
- Jan 24
HeraMED Appoints Keith Koby as President in North America
Keith Koby, formerly Senior Vice President, North America at Nanosonics, one of Australia’s most successful medical technology companies,...
- Jan 10
Maternity Care Deserts: Definitions + Solutions to Improve Prenatal Care Access
This nonprofit March of Dimes map shows maternity care deserts across the U.S. in 2020. March of Dimes/US Health Resources and Services...
- Dec 27, 2022
Remote Pregnancy Monitoring a Game Changer for Expectant Moms in Areas Impacted by Extreme Weather
Remote pregnancy monitoring technology has the potential to be a game-changer for expectant mothers living in areas prone to extreme...
- Nov 22, 2022
Ramsay affiliated “Melbourne-Mothers” private practice signed agreement to adopt HeraCARE
Leading obstetrician and gynaecologist Associate Professor Vinay Rane, will lead the first private clinic commercial HeraCARE launch in...
- Nov 8, 2022
JHC’s Clinical Trial peer-reviewed and published in Nature Portfolio
Results from the second clinical study by Joondalup Health Campus (JHC) have been published in Nature magazine’s digital health platform...
- Oct 26, 2022
HeraCARE at Northside Women's in Atlanta: A Patient's Story
The Virtual OB program at Northside Women's Specialists, a Peditrix Practice in Atlanta Georgia powered by HeraCARE, saves moms time,...
- Sep 13, 2022
Appointment of Emily Slade as a Non-Executive Director
HeraMED is pleased to announce the appointment of Emily Slade as a Non-Executive Director, with immediate effect. Throughout her...
- Aug 24, 2022
HeraMED completes AU$4.0m
HeraMED successfully raises $4.0 million (before costs) in a private placement to sophisticated and professional investors The raising...
- Jul 28, 2022
HeraMED and e-Lōvu Health form strategic partnership for HeraCARE deployment in the US
HeraMED signs a binding term sheet to supply SaaS-based HeraCARE platform licensing and technology to e-Lōvu Health, a clinically guided...
- Jul 26, 2022
Experienced senior executive Anoushka Gungadin appointed as HeraMED’s director of strategic partners
HeraMED appoints highly regarded senior executive and entrepreneur Ms Anoushka Gungadin as its director of strategic partnerships,...
- Jul 18, 2022
HeraMED, Project Rozana & Sheba Beyond join to provide maternal telemedicine to Palestinian mothers
HeraMED, a medical data and technology company leading the digital transformation of maternity care, is pleased to announce that our...
- Jul 18, 2022
Sheba’s HeraBEAT telemedicine clinical trial completed with excellent results
Just-released results from a clinical trial undertaken by Israel’s Sheba Medical Center conclude that the HeraBEAT smart fetal HR monitor...
- Apr 21, 2022
HeraMED’s Virtual OB Pilot gains excellent scores from patients and providers
Medical technology company HeraMED Limited (ASX:HMD) has released an upbeat update concerning a Virtual OB Paid Pilot undertaken by...
- Mar 12, 2022
Ukraine war: Israeli femtech to help save the lives of moms and babies
An estimated 80,000 Ukrainian women will give birth in the next three months without access to critical maternal care as a result of the...
- Jan 22, 2022
HeraMED signs “significant milestone” with a Perth hospital
A Perth hospital has agreed to a full commercial rollout of HeraMED’s (HMD) HeraCARE. The Joondalup Health Campus (JHC) will use HeraCARE...
- Jan 22, 2022
HeraMED strikes a deal with Joondalup Health Campus
Manufacturer and distributor of pregnancy-related solutions and heartbeat monitors, HeraMED Limited (ASX:HMD) has signed a commercial...
- Jul 20, 2021
HeraCARE to Pilot in the US
Medical data and technology company HeraMED (ASX: HMD) has today announced a partnership to accelerate their mission to revolutionize...
News
bottom of page